Based on our observation, reviewing all the available demographic, clinical and laboratory variables in our cohort, we strongly suggest that low albumin level on admission or progressive decline during the hospital stay should not be neglected and advise further research to see if normalizing the levels will have any impact on survival of the COVID infected cancer patients. The gene discussed is ALB; the disease is cancer.